[2] In March 2026, the FDA sent warning letters to 30 telehealth companies over misleading marketing of compounded GLP-1 products
Among patients with prediabetes at the start of the study, 91% achieved healthy blood sugar levels in the medication group, compared with 42% in the placebo group
BPC-157 is part of our broader peptides Canada lineup and is commonly featured alongside other high-demand compounds such as TB-500, KPV, GHK-Cu, and select peptide blends
As of now, there are no formal, large-scale human clinical trials that have specifically studied the effects of BPC-157 on diverticulitis
Oral naevus (mole) , a small, stable pigmented bump that has been present for years
Background Diabetes, a chronic metabolic condition characterized by high blood glucose levels, is becoming a major public health concern worldwide, with a projected increase in its prevalence from 537 million in 2021 to 783 million by 2045